Xijuan Yao
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Nanoscale CaO2-Loaded Surface-Engineered Iodine-125 Seed with Sustained Self-Oxygenation for Sensitized Tumor Brachytherapy.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: November 27, 2024
P4HA2 interacted with ATAD3A to modulate PINK1/parkin-dependent mitophagy and 125I brachytherapy sensitization in esophageal carcinoma.
Journal: Cell death & disease
Published: September 26, 2024
Identification of a novel peptide targeting TIGIT to evaluate immunomodulation of 125I seed brachytherapy in HCC by near-infrared fluorescence.
Journal: Frontiers in oncology
Published: January 12, 2023
Tumor oxygenation nanoliposome synergistic hypoxia-inducible-factor-1 inhibitor enhanced Iodine-125 seed brachytherapy for esophageal cancer.
Journal: Biomaterials
Published: May 12, 2022
Microorganism-enabled photosynthetic oxygeneration and ferroptosis induction reshape tumor microenvironment for augmented nanodynamic therapy.
Journal: Biomaterials
Published: May 10, 2022
Interventional Treatment for Cholangiocarcinoma.
Journal: Frontiers in oncology
Published: February 23, 2021
CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells.
Journal: Molecular medicine reports
Published: October 11, 2020
Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 09, 2020
DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies.
Journal: Journal of cellular physiology
Published: February 17, 2020
Last Updated: 09/26/2026